Immunomedics Common
|
18.4 |
$930M |
|
26M |
35.44 |
Mirati Therapeutics Common
|
9.7 |
$489M |
|
4.3M |
114.17 |
Horizon Therapeutics Common
|
6.6 |
$334M |
|
6.0M |
55.58 |
Iovance Biotherapeutics Common
(IOVA)
|
5.6 |
$284M |
|
10M |
27.45 |
Sarepta Therapeutics Common
(SRPT)
|
5.3 |
$269M |
|
1.7M |
160.34 |
Ascendis Pharma Sponsored ADR
(ASND)
|
5.1 |
$259M |
|
1.8M |
147.90 |
Biomarin Pharmaceutical Common
(BMRN)
|
4.5 |
$228M |
|
1.9M |
123.34 |
Argenx Se Sponsored ADR
(ARGX)
|
4.3 |
$219M |
|
970k |
225.23 |
Myokardia Common
|
3.6 |
$182M |
|
1.9M |
96.62 |
Amicus Therapeutics Common
(FOLD)
|
3.3 |
$166M |
|
11M |
15.08 |
Adverum Biotechnologies Common
|
3.1 |
$158M |
|
7.6M |
20.88 |
Mersana Therapeutics Common
(MRSN)
|
3.0 |
$152M |
|
6.5M |
23.40 |
Karyopharm Therapeutics Common
(KPTI)
|
2.6 |
$133M |
|
7.0M |
18.94 |
Constellation Pharmaceuticals Common
|
2.4 |
$120M |
|
4.0M |
30.05 |
Deciphera Pharmaceuticals Common
|
2.2 |
$111M |
|
1.9M |
59.72 |
Adaptimmune Therapeutics Sponsored ADR
(ADAP)
|
2.0 |
$102M |
|
10M |
10.01 |
Acceleron Pharma Common
|
2.0 |
$99M |
|
1.0M |
95.27 |
Uniqure Nv Common
(QURE)
|
1.3 |
$68M |
|
1.5M |
45.06 |
Relmada Therapeutics Common
(RLMD)
|
1.3 |
$64M |
|
1.4M |
44.75 |
Zogenix Common
|
1.2 |
$61M |
|
2.3M |
27.01 |
Arena Pharmaceuticals Common
|
1.2 |
$60M |
|
950k |
62.95 |
Athenex Common
|
1.0 |
$53M |
|
3.9M |
13.76 |
Allogene Therapeutics Common
(ALLO)
|
1.0 |
$48M |
|
1.1M |
42.82 |
Cue Biopharma Common
(CUE)
|
0.9 |
$46M |
|
1.9M |
24.51 |
Madrigal Pharmaceuticals Common
(MDGL)
|
0.8 |
$40M |
|
350k |
113.25 |
Trillium Therapeutics Common
|
0.8 |
$38M |
|
4.8M |
8.09 |
Avadel Pharmaceuticals Sponsored ADR
|
0.7 |
$37M |
|
4.6M |
8.08 |
Iveric Bio Common
|
0.7 |
$36M |
|
7.1M |
5.10 |
Xenon Pharmaceuticals Common
(XENE)
|
0.7 |
$35M |
|
2.8M |
12.54 |
Marinus Pharmaceuticals Common
|
0.6 |
$30M |
|
12M |
2.54 |
Aurinia Pharmaceuticals Common
(AUPH)
|
0.5 |
$27M |
|
1.7M |
16.25 |
Black Diamond Therapeutics Common
(BDTX)
|
0.4 |
$22M |
|
525k |
42.16 |
Retrophin Common
|
0.4 |
$21M |
|
1.1M |
20.41 |
Cymabay Therapeutics Common
|
0.4 |
$18M |
|
5.3M |
3.49 |
Kura Oncology Common
(KURA)
|
0.3 |
$17M |
|
1.1M |
16.30 |
Avidity Biosciences Common
(RNA)
|
0.3 |
$17M |
|
585k |
28.26 |
Tricida Common
|
0.3 |
$17M |
|
600k |
27.48 |
Ptc Therapeutics Common
(PTCT)
|
0.3 |
$17M |
|
325k |
50.74 |
Fennec Pharmaceuticals Common
(FENC)
|
0.3 |
$14M |
|
1.7M |
8.35 |
Amarin Corp Sponsored ADR
(AMRN)
|
0.3 |
$14M |
|
2.0M |
6.92 |
Revolution Medicines Common
(RVMD)
|
0.2 |
$9.6M |
|
304k |
31.57 |
Biodelivery Sciences Intl Common
|
0.2 |
$8.9M |
|
2.0M |
4.36 |
Cardiff Oncology Common
(CRDF)
|
0.1 |
$5.0M |
|
1.0M |
5.01 |
Alimera Sciences Common
|
0.1 |
$2.6M |
|
416k |
6.30 |